GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitae Corp (OTCPK:NVTAQ) » Definitions » Cyclically Adjusted PB Ratio

Invitae (Invitae) Cyclically Adjusted PB Ratio : 0.00 (As of Apr. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invitae Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Invitae's current share price is $0.0005. Invitae's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $4.51. Invitae's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Invitae's Cyclically Adjusted PB Ratio or its related term are showing as below:

During the past years, Invitae's highest Cyclically Adjusted PB Ratio was 0.33. The lowest was 0.09. And the median was 0.19.

NVTAQ's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.97
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Invitae's adjusted book value per share data for the three months ended in Sep. 2023 was $-3.782. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.51 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Invitae Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Invitae's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitae Cyclically Adjusted PB Ratio Chart

Invitae Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Invitae Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.29 0.24 0.13

Competitive Comparison of Invitae's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Invitae's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitae's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitae's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Invitae's Cyclically Adjusted PB Ratio falls into.



Invitae Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Invitae's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0005/4.51
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitae's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Invitae's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-3.782/129.8595*129.8595
=-3.782

Current CPI (Sep. 2023) = 129.8595.

Invitae Quarterly Data

Book Value per Share CPI Adj_Book
201312 -2.505 98.326 -3.308
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 2.186 100.428 2.827
201412 -2.805 99.070 -3.677
201503 6.489 99.621 8.459
201506 5.741 100.684 7.405
201509 5.046 100.392 6.527
201512 4.333 99.792 5.639
201603 3.575 100.470 4.621
201606 2.873 101.688 3.669
201609 2.183 101.861 2.783
201612 2.408 101.863 3.070
201703 1.945 102.862 2.455
201706 1.542 103.349 1.938
201709 2.497 104.136 3.114
201712 2.272 104.011 2.837
201803 1.898 105.290 2.341
201806 2.010 106.317 2.455
201809 2.404 106.507 2.931
201812 2.144 105.998 2.627
201903 3.531 107.251 4.275
201906 3.642 108.070 4.376
201909 4.185 108.329 5.017
201912 3.843 108.420 4.603
202003 3.200 108.902 3.816
202006 3.536 108.767 4.222
202009 3.126 109.815 3.697
202012 10.632 109.897 12.563
202103 12.031 111.754 13.980
202106 13.073 114.631 14.810
202109 13.733 115.734 15.409
202112 13.057 117.630 14.415
202203 12.428 121.301 13.305
202206 1.644 125.017 1.708
202209 0.654 125.227 0.678
202212 0.415 125.222 0.430
202303 -0.141 127.348 -0.144
202306 -0.753 128.729 -0.760
202309 -3.782 129.860 -3.782

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Invitae  (OTCPK:NVTAQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Invitae Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Invitae's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitae (Invitae) Business Description

Traded in Other Exchanges
Address
1400 16th Street, San Francisco, CA, USA, 94103
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.
Executives
Ana J. Schrank officer: Chief Financial Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
Robert M. Guigley officer: Chief Commercial Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
Robert Iv Dickey officer: See Remarks 320 WEST MERMAID LANE, PHILADELPHIA PA 19118
Jeff Parsons officer: See remarks 2575 AUGUSTINE DRIVE, SANTA CLARA CA 95054
Robert L Nussbaum officer: Chief Medical Officer 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Thomas Brida officer: General Counsel 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Robert F. Werner officer: Chief Accounting Officer 2500 FABER PLACE, PALO ALTO CA 94303
Yafei Wen officer: Chief Financial Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
Kenneth D. Knight officer: Chief Operating Officer 1400 16TH STREET, SAN FRANCISCO CA 94103
William H Osborne director 1415 WEST 22ND STREET, SUITE 1100, OAK BROOK IL 60523
Sean E George director, officer: CEO 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Shelly D Guyer officer: Chief Financial Officer 1025 GREEN STREET, SAN FRANCISCO CA 94133
Katherine Stueland officer: Chief Commercial Officer 458 BRANNAN STREET, SAN FRANCISCO CA 94107
Geoffrey Crouse director 3130 GATEWAY DRIVE, P O BOX 5625, NORCROSS GA 30091-5625
Jason W. Myers director, other: President, Oncology C/O ARCHERDX, INC., 2477 55TH STREET, SUITE 202, BOULDER CO 80301